Journal
NUCLEIC ACIDS RESEARCH
Volume 29, Issue 11, Pages 2276-2283Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/29.11.2276
Keywords
-
Categories
Funding
- NICHD NIH HHS [HD35576, P01 HD035576, HD20521, R01 HD020521, R37 HD020521] Funding Source: Medline
Ask authors/readers for more resources
Fragile X syndrome is a frequent form of inherited mental retardation caused by functional loss of the fragile X mental retardation protein, FMRP, The function of FMRP is unknown, as is the mechanism by which its loss leads to cognitive deficits. Recent studies have determined that FMRP is a selective RNA-binding protein associated with polyribosomes, leading to the hypothesis that FMRP may be involved in translational regulation. Here we show that purified recombinant FMRP causes a dose-dependent translational inhibition of brain poly(A) RNA in rabbit reticulocyte lysate without accelerated mRNA degradation. In our translation reaction FMRP interacts with other messenger ribonucleoproteins and preexposure of FMRP to mRNA significantly increased the potency of FMRP as a translation inhibitor. Translation suppression by FMRP is reversed in a transacting manner by the 3'-untranslated portion of the Fmr1 message, which binds FMRP, suggesting that FMRP inhibits translation via interacting with mRNA, Consistently FMRP suppresses translation of the parathyroid hormone transcript, which binds FMRP, but not the beta -globin transcript, which does not bind FMRP, Moreover, removing the FMRP-binding site on a translation template abolishes the inhibitory effect of FMRP, Taken together, our results support the hypothesis that FMRP inhibits translation via interactions with the translation template.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available